However, more recently, deep-sequencing studies have highlighted the importance of acquired mutations of ER in driving resistance [10], where acquisition of such mutations renders the cancer cells insensitive to AIs and is predicted to reduce sensitivity to anti-estrogens [3, 11]. Here, ESR1 is linked to cancer.